Transforming growth factor-beta as a therapeutic target

Transforming growth factor-beta (TGF-beta) family members include TGF-beta, activins, and bone morphogenetic proteins (BMP). These proteins are structurally related cytokines secreted in diverse Metazoans. TGF-beta family members regulate cellular functions such as proliferation, apoptosis, differen...

Full description

Saved in:
Bibliographic Details
Published in:Salud pública de México 2004-07, Vol.46 (4), p.341
Main Authors: Gálvez-Gastélum, Francisco Javier, Sandoval-Rodríguez, Ana Soledad, Armendáriz-Borunda, Juan
Format: Article
Language:Spanish
Subjects:
Animals
Clinical Trials as Topic
Humans
Phosphorylation
Transforming Growth Factor beta - therapeutic use
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Transforming growth factor-beta (TGF-beta) family members include TGF-beta, activins, and bone morphogenetic proteins (BMP). These proteins are structurally related cytokines secreted in diverse Metazoans. TGF-beta family members regulate cellular functions such as proliferation, apoptosis, differentiation, and migration, and play an important role in organism development. Deregulated TGF-beta family signaling participates in various human pathologies including autoimmune diseases, vascular disorders, fibrotic disease, and cancer. Ligand-induced activation of TGF-beta family receptors with intrinsic serine/threonine kinase activity, triggers phosphorylation of the intracellular effectors of TGF-beta signaling, the Smads proteins. Once these proteins are activated they translocate into the nucleus, where they induce transcription of target genes and regulate cellular processes and functions. Novel therapeutic strategies are currently being developed to correct alterations in pathologies that involve TGF-beta as the main mediator. The English version of this paper is available at: http://www.insp.mx/salud/index.html.
ISSN:0036-3634
DOI:10.1590/S0036-36342004000400009